Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  CSPC Pharmaceutical Group Ltd    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LTD

(1093)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CSPC Pharmaceutical Group Ltd : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/22/2018 | 09:15am EDT

The company will report its earnings for Q1 2018 on 05/25/2018. Generally, the company reports earnings worse than estimates. In recent months, the 22 analysts from Thomson Reuters consensus have revised their EPS estimates upward.


© MarketScreener.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CSPC PHARMACEUTICAL GROUP
05/30ASIA MARKETS: Asian Markets In A Tug Of War As Investors Eye Trade Spat
DJ
05/30CSPC PHARMACEUTICAL GROUP LTD : Ex-dividend day for final dividend
FA
05/10ASIA MARKETS: China Stocks Soar To Best One-day Gain Since March, As U.S. Tar..
DJ
05/07ASIA MARKETS: China Stocks Drop 5.5%, Leading Asia Markets Lower As U.S.-Chin..
DJ
04/16ASIA MARKETS: Asian Markets Little Changed As China's Economy Holds Steady
DJ
03/19ASIA MARKETS: Asian Markets Muted, Awaiting Upcoming Fed Meeting
DJ
03/18CSPC PHARMACEUTICAL : Pharma year net up 32% to HK$3.65 billion
AQ
02/11ASIA MARKETS: Asian Markets Gain As Investors Pin Hopes On U.S.-China Trade T..
DJ
02/08ASIA MARKETS: Asian Markets Drop On Renewed Worries Over U.S.-China Trade Tal..
DJ
02/04ASIA MARKETS: Asian Markets Mixed Amid Holiday Closures; Sony Sinks
DJ
More news
Financials (HKD)
Sales 2019 25 492 M
EBIT 2019 5 526 M
Net income 2019 4 467 M
Finance 2019 6 582 M
Yield 2019 1,93%
P/E ratio 2019 17,10
P/E ratio 2020 13,97
EV / Sales 2019 2,72x
EV / Sales 2020 2,19x
Capitalization 76 030 M
Chart CSPC PHARMACEUTICAL GROUP LTD
Duration : Period :
CSPC Pharmaceutical Group Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 36
Average target price 18,2  HKD
Spread / Average Target 49%
EPS Revisions
Managers
NameTitle
Dong Chen Cai Chairman & Co-Chief Executive Officer
Zhen Guo Wang Vice Chairman & Co-Chief Executive Officer
Wei Dong Pan Vice Chairman
Ka Sze Lee Secretary & Non-Executive Director
Huai Yu Wang Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSPC PHARMACEUTICAL GROUP LTD8.53%9 988
JOHNSON & JOHNSON10.10%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.87%227 848
NOVARTIS21.31%220 893
MERCK AND COMPANY10.68%206 641